Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Discovery may help complications of diabetes - delayed gastric emptying or gastroparesis

Mayo Clinic researchers have found what may provide a solution to one of the more troubling complications of diabetes -- delayed gastric emptying or gastroparesis.

25 Sep 2008

New pig model of cystic fibrosis provides better understanding of human disease

For the first time, researchers have developed a genetically altered animal model for cystic fibrosis (CF) that closely matches the characteristics of the disease in humans. By studying the complex and multi-organ disease process in the pig model, researchers can now better understand how the complications of CF develop, an advancement that may lead to new avenues for research in prevention and treatment.

25 Sep 2008

Chinese baby milk scandal spreads to countries across Asia

The latest victim of the Chinese baby milk scandal appears to be the head of the country's quality watchdog, who has resigned.

23 Sep 2008

Almost 13,000 Chinese babies now sick from contaminated milk

China's Health Ministry says almost 13,000 babies have been taken to hospital suffering from the effects of drinking milk contaminated with the chemical melamine - most 2 years old or younger and four children have already died.

22 Sep 2008

New type of gene manipulation therapy offers hope for Duchenne muscular dystrophy sufferers

A medical research team at Carolinas Medical Center in Charlotte headed by Qi Long Lu, M.D., Ph.D., has made a discovery that holds promise to restore muscle function in patients afflicted by Duchenne muscular dystrophy (DMD).

21 Sep 2008

Toxic baby milk shocks China

In China's latest food scare 6,000 babies have been poisoned and three babies have died from drinking baby milk tainted by the industrial chemical melamine.

18 Sep 2008

24 percent of U.S. women affected by pelvic floor disorders

Nearly 24 percent of U.S. women are affected with one or more pelvic floor disorders, report researchers funded by the National Institutes of Health. Their analysis is the first to document in a nationally representative sample the extent of pelvic floor disorders, a cluster of health problems that causes physical discomfort and limits activity.

17 Sep 2008

Gastric bypass surgery does not always guarantee a significant weight loss

According to a new report gastric bypass surgery is not always a great success story.

17 Sep 2008

Scientists identify kidney failure susceptibility gene

Scientists at Johns Hopkins schools of Public Health and Medicine have, for the first time, identified variants in the gene MYH9 that are associated with increased risk for non-diabetic end stage renal disease (ESRD,) which is the near-loss of kidney function leading to either dialysis of transplant. MYH9, located on the 22 chromosome, is the first gene identified for common forms of kidney disease.

15 Sep 2008

Experts say thousands at risk for heart disease go unchecked

Australian experts say thousands at risk for heart disease go unchecked and are not getting the drugs which protect them.

15 Sep 2008

FDA issues warning on milk-based infant formula manufactured in China

In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) is issuing a Health Information Advisory.

14 Sep 2008

Depressed dialysis patients more likely to be hospitalized or die, researcher finds

Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.

14 Sep 2008

New treatment for diabetics identified

Some of the most serious health complications associated with diabetes could be prevented or delayed by taking a widely available cholesterol-lowering drug which has already been on the market for three decades, new research has shown.

8 Sep 2008

In just 5 years tobacco caused 2.4 million cases of cancer in the U.S.

The latest report from the Centers for Disease Control and Prevention (CDC) in the U.S. reveals some shocking figures.

8 Sep 2008

Living sensor can warn of arsenic pollution

Scientists studying arsenic pollution have discovered a living sensor that can spot contamination. They have also discovered new bacteria that can clean up arsenic spills even in previously untreatable cold areas, microbiologists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

7 Sep 2008

NIH tackles urologic chronic pelvic pain disorders

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.

7 Sep 2008

Public backs tougher tobacco control to protect the young

More than 8,000 people have written to the Department of Health calling for tougher tobacco control to protect young people and put tobacco out of sight and out of mind.

7 Sep 2008

High gas prices lead U.S. residents who travel far, frequently for medical treatment to skip, delay appointments

Many U.S. residents with illnesses who must travel frequently or long distances for treatment are forgoing, cutting back or delaying appointments and support groups or applying for grants to offset high gasoline prices, USA Today reports.

5 Sep 2008

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Cancer drug developer Antisoma plc today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma (kidney cancer).

4 Sep 2008

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.

3 Sep 2008